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INTRODUCTION 
The Medicare Access and CHIP 
Reauthorization Act (MACRA) changes 
reimbursement from a fee-for-service payment 
system to fee-for-value. Physicians will be 
scored according to the quality of their care in 
the MIPS program and will receive a positive or 
negative modifier to their Medicare 
reimbursement based on that score. 
OBJECTIVE:  
To analyze a cost-effective model for 
Negative Pressure Wound Therapy (NPWT) 
devices with attention to how a MIPS score is 
affected. 
MATERIAL AND METHODS 
 Three devices from KCI and Smith & 
Nephew each were compared for cost-
effectiveness and MIPS score impact. From 
KCI, the V.A.C.Ulta, ActiV.A.C., and SNaP 
devices were compared to the S&N RENASYS, 
RENASYS GO, and PICO devices respectively. 
Impact on the MIPS sections of Quality, Cost, 
and Clinical Practice Improvement Activities 
(CPIA) were taken into account. Participation in 
Alternative Payment Models was not analyzed. 
RESULTS & CONCLUSION 
Due to the variability of wound 
treatment, the devices were compared to each 
other based on the types of wounds they are 
typically indicated for. If a wound requires 
inpatient care, the KCI V.A.C.Ulta with 
instillation therapy is the better choice because it 
reduces infection rates and treats more complex 
wounds faster than traditional NPWT as seen 
with the RENASYS device. This improves the 
Quality score because of lower infection rates 
and it improves the Cost score because wounds 
heal faster and discharge comes earlier. If the 
wound can be cared for on an outpatient basis, 
the KCI SNaP mechanical device is the best 
option because it is the cheapest, most cost-
effective choice over the S&N PICO device. The 
SNaP and PICO devices are better options than 
the ActiV.A.C and RENASYS GO devices 
because they are ultra-lightweight, require no 
canister for exudate, and can fit in a discreet 
pouch or pocket which is highly beneficial for 
patient satisfaction and the CPIA section score. 
If the wound can be cared for on an outpatient 
basis, but is too large or produces too much 
exudate for the SNaP and PICO devices, the 
KCI ActiV.A.C and S&N RENASYS Go 
devices are better options. Between these two 
devices the RENASYS GO is more cost 
effective and thus improves the Cost score. 
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